Literature DB >> 28722268

Downregulation of microRNA-15a-3p is correlated with clinical outcome and negatively regulates cancer proliferation and migration in human osteosarcoma.

Jiyuan Shi1,2, Qiang Fu3, Pei Yang2, Huitong Liu1, Le Ji1, Kunzheng Wang1,2.   

Abstract

In this study, we investigated the expression, correlation to clinical outcomes and biological functions of microRNA-15a-3p (miR-15a-3p) in human osteosarcoma. MiR-15a-3p expressions in osteosarcoma cell lines and clinical tissues of osteosarcoma patients were measured by qPCR. Relevance of endogenous miR-15a-3p to osteosarcoma patients' clinicopathological factors or overall survival was statistically analyzed. In addition, the independence of miR-15a-3p predicting cancer patients' overall survival was analyzed by Cox regression method. Furthermore, in osteosarcoma cell lines, Saos-2 and HOS cells, miR-15a-3p was overexpressed through stable lentiviral transduction. The functional regulations of miR-15a-3p overexpression on cancer ell proliferation and migration were then analyzed. MiR-15a-3p was significantly downregulated in osteosarcoma cell lines and human osteosarcoma tumors. Downregulation of endogenous miR-15a-3p in osteosarcoma tumors was significantly associated with cancer patient's poor clinical outcomes and low survival rate. Also, endogenous miR-15a-3p was confirmed to be an independent biomarker for predicating cancer patients' survival. In Saos-2 and HOS cells, lentivirus-induced miR-15a-3p overexpression had significantly tumor suppressing functions, by inhibiting both proliferation and migration. Significant downregulation of miR-15a-3p in osteosarcoma may be an independent biomarker to predicting cancer patients' poor prognosis. Overexpression miR-15a-3p may be an efficient functional meaning to suppress osteosarcoma development.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  clinical outcome; miR-15a-3p; osteosarcoma; overall survival; proliferation

Mesh:

Substances:

Year:  2017        PMID: 28722268     DOI: 10.1002/jcb.26294

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Therapeutic effects of oligo-single-stranded DNA mimicking of hsa-miR-15a-5p on multiple myeloma.

Authors:  Zhongqing Li; Lanting Liu; Chenxing Du; Zhen Yu; Yuanyuan Yang; Jie Xu; Xiaojing Wei; Fenghuang Zhan; Yongrong Lai; Lugui Qiu; Mu Hao
Journal:  Cancer Gene Ther       Date:  2020-01-28       Impact factor: 5.987

3.  Prognostic Value of MicroRNA-15a in Human Cancers: A Meta-Analysis and Bioinformatics.

Authors:  Fei-Ran Yang; Hui-Jie Li; Ting-Ting Li; Yu-Feng Zhao; Zong-Kai Liu; Xiu-Rong Li
Journal:  Biomed Res Int       Date:  2019-04-02       Impact factor: 3.411

4.  Naringin targets Zeb1 to suppress osteosarcoma cell proliferation and metastasis.

Authors:  He Ming; Qiu Chuang; Wang Jiashi; Li Bin; Wang Guangbin; Ji Xianglu
Journal:  Aging (Albany NY)       Date:  2018-12-22       Impact factor: 5.682

5.  Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway.

Authors:  Chunyu Wu; Zhigang Li; Guang Feng; Liqin Wang; Jingri Xie; Yang Jin; Long Wang; Songjiang Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.